Design Therapeutics RESTORE-FA trial updates page
On 4th June 2025, the Biotechnology company Design Therapeutics announced that they have dosed the first person with Friedreich’s ataxia (FA) in their phase 1 clinical trial of their drug […]
Design Therapeutics RESTORE-FA trial updates page Read More »